Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs

Journal of the American Pharmacists Association

Volumn 50, Issue 4, 2010, Pages 527-531

  Yang, Yi ^a   Thumula, Vennela ^a   Pace, Patrick F ^a   Banahan III, Benjamin F ^a   Wilkin, Noel E ^a   Lobb, William B ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b Medical Marketing Economics   (United States)

Author keywords

Adherence (medication); Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Diabetes; Medicare Part D

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; DIABETES MELLITUS; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MEDICARE; PATIENT COMPLIANCE; STATISTICS; UNITED STATES;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MEDICARE PART D; MEDICATION ADHERENCE; UNITED STATES;

EID: 78149479186     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09071     Document Type: Article

References (19)

1. Arauz-Pacheco C, Parrott MA, Raskin P. Hypertension management in adults with diabetes. Diabetes Care. 2004;27(suppl 1):S65-7.
2. Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(suppl 1):S79-83.
3. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-9.
4. Brenner BM, Cooper ME, de Zeeuw D, Keane WF et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-9.
5. Estacio RO, Jeffers BW, Hiatt WR, et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998;338:645-52.
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-62.
7. Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-76.
8. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32(suppl 1):S13-61.
9. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(suppl 1):1-68.
10. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27:1064-73.
11. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-41.
12. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-53.
13. Agency for Healthcare Research and Quality. Guide to prevention quality indicators: revision 3.1. Accessed at www.qualityindicators.ahrq.gov/downloads/ pqi/pqi-guide-v31.pdf, December 18, 2009.
14. Cerner Multum. Multum Lexicon. Accessed at www.multum.com/Lexicon.htm, December 18, 2009.
15. Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10(1):3-12.
16. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118(suppl 5A):27-34S.
17. Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24.
18. Shaya FT, Du D, Gbarayor CM, et al. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J Natl Med Assoc. 2009;101(1):34-9.
19. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;CD000011.